7 Key Takeaways | The Changing Landscape of Federal Funding in the Trump Administration
The U.S. government is pushing to redomesticate the manufacturing of pharmaceutical, biotech, gene therapy, and medical device products, both to bolster U.S. manufacturing generally and to address continuing shortages of...more
The lack of readily available funds that often exists within a growing small or medium technology enterprise (Tech-SME) can result in management having to juggle many competing priorities; unfortunately, this sometimes means...more